Chief Investigator:

Prof Richard Riley

Principal Investigator:

Dr Shakila Thangaratinam (BARTS) Queen Mary University of London (QMUL) 

Funder name / reference number: National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme. REC ref. 11/WM/0248
Year 2012 - 2015 (30 months) - almost published with HTA.

Study design

A cohort study

Primary objective

To develop and externally validate a prognostic model for adverse outcomes in women with suspected pre-eclampsia and to assess the risk of adverse fetal and neonatal outcomes at birth and by discharge.